| Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples F Karami, S Ranjbar, Y Ghasemi, M Negahdaripour Journal of Pharmaceutical Analysis 9 (6), 373-391, 2019 | 79 | 2019 |
| Click chemistry-assisted synthesis of novel aminonaphthoquinone-1, 2, 3-triazole hybrids and investigation of their cytotoxicity and cancer cell cycle alterations M Gholampour, S Ranjbar, N Edraki, M Mohabbati, O Firuzi, ... Bioorganic Chemistry 88, 102967, 2019 | 74 | 2019 |
| Synthesis of new benzimidazole‐1, 2, 3‐triazole hybrids as tyrosinase inhibitors M Mahdavi, A Ashtari, M Khoshneviszadeh, S Ranjbar, A Dehghani, ... Chemistry & Biodiversity 15 (7), e1800120, 2018 | 54 | 2018 |
| Phthalimide-1, 2, 3-triazole hybrid compounds as tyrosinase inhibitors; synthesis, biological evaluation and molecular docking analysis MB Tehrani, P Emani, Z Rezaei, M Khoshneviszadeh, M Ebrahimi, ... Journal of Molecular Structure 1176, 86-93, 2019 | 44 | 2019 |
| 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells S Ranjbar, R Khonkarn, A Moreno, H Baubichon-Cortay, R Miri, ... Toxicology and Applied Pharmacology 362, 136-149, 2019 | 40 | 2019 |
| 5-Oxo-hexahydroquinoline: An attractive scaffold with diverse biological activities S Ranjbar, N Edraki, O Firuzi, M Khoshneviszadeh, R Miri Molecular Diversity 23, 471-508, 2019 | 38 | 2019 |
| 1, 2, 3‐Triazole‐linked 5‐benzylidene (thio) barbiturates as novel tyrosinase inhibitors and free‐radical scavengers S Ranjbar, P Shahvaran, N Edraki, M Khoshneviszadeh, M Darroudi, ... Archiv der Pharmazie 353 (10), 2000058, 2020 | 25 | 2020 |
| Novel morpholine containing cinnamoyl amides as potent tyrosinase inhibitors S Ghafary, S Ranjbar, B Larijani, M Amini, M Biglar, M Mahdavi, ... International journal of biological macromolecules 135, 978-985, 2019 | 23 | 2019 |
| Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers Z Dehghani, M Khoshneviszadeh, M Khoshneviszadeh, S Ranjbar Bioorganic & medicinal chemistry 27 (12), 2644-2651, 2019 | 23 | 2019 |
| Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study O Shahraki, N Edraki, M Khoshneviszadeh, F Zargari, S Ranjbar, L Saso, ... Drug design, development and therapy, 407-418, 2017 | 23 | 2017 |
| 4H-benzochromene derivatives as novel tyrosinase inhibitors and radical scavengers: synthesis, biological evaluation, and molecular docking analysis S Karimian, S Ranjbar, M Dadfar, M Khoshneviszadeh, M Gholampour, ... Molecular Diversity 25, 2339-2349, 2021 | 21 | 2021 |
| Synthesis of Novel Triazole Incorporated Thiazolone Motifs Having Promising Antityrosinase Activity through Green Nanocatalyst CuI‐Fe3O4@SiO2 (TMS‐EDTA) M Darroudi, S Ranjbar, M Esfandiar, M Khoshneviszadeh, ... Applied Organometallic Chemistry 34 (12), e5962, 2020 | 20 | 2020 |
| 6-Methoxy-3, 4-dihydronaphthalenone chalcone-like derivatives as potent tyrosinase inhibitors and radical scavengers S Ranjbar, A Akbari, N Edraki, M Khoshneviszadeh, H Hemmatian, ... Letters in Drug Design & Discovery 15 (11), 1170-1179, 2018 | 20 | 2018 |
| Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis S Ranjbar, O Firuzi, N Edraki, O Shahraki, L Saso, M Khoshneviszadeh, ... MedChemComm 8 (10), 1919-1933, 2017 | 20 | 2017 |
| Design, synthesis, cytotoxicity evaluation and docking studies of 1, 2, 4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors S Ranjbar, N Edraki, M Khoshneviszadeh, A Foroumadi, R Miri, ... Research in Pharmaceutical Sciences 13 (1), 1-11, 2018 | 19 | 2018 |
| 5-Oxo-hexahydroquinoline and 5-oxo-tetrahydrocyclopentapyridine derivatives as promising antiproliferative agents with potential apoptosis-inducing capacity S Ranjbar, M Khoshneviszadeh, M Tavakkoli, R Miri, N Edraki, O Firuzi Molecular Diversity, 1-20, 2022 | 6 | 2022 |
| Novel cytotoxic phenanthro-triazine-3-thiol derivatives as potential DNA intercalators and Bcl-2 inhibitors M Khoshneviszadeh, O Firuzi, M Aminsafaee, M Kashefizadeh, S Ranjbar, ... Iranian Journal of Pharmaceutical Research: IJPR 20 (3), 161, 2021 | 6 | 2021 |
| Discovery of novel 4, 5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies S Zareei, S Ranjbar, M Mohammadi, Y Ghasemi, S Golestanian, ... Bioorganic Chemistry 141, 106846, 2023 | 4 | 2023 |
| Benzylidene-6-hydroxy-3, 4-dihydronaphthalenone chalconoids as potent tyrosinase inhibitors S Ranjbar, MM Kamarei, M Khoshneviszadeh, H Hosseinpoor, N Edraki, ... Research in Pharmaceutical Sciences 16 (4), 425-435, 2021 | 4 | 2021 |
| Anti-Toxoplasma gondii activity of 5-oxo-hexahydroquinoline derivatives: synthesis: in vitro: and: in vivo: evaluations, and molecular docking analysis M Zahedi, Q Asgari, F Badakhshan, A Sakhteman, S Ranjbar, ... Research in Pharmaceutical Sciences 15 (4), 367-380, 2020 | 4 | 2020 |
Mehdi KhoshneviszadehAssociate professor of Medicinal chemistry, Shiraz University of Medical Sciences在 sums.ac.ir 的电子邮件经过验证
